These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2594922)
1. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922 [TBL] [Abstract][Full Text] [Related]
2. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Heffner TG; Seiden LS Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184 [TBL] [Abstract][Full Text] [Related]
3. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924 [TBL] [Abstract][Full Text] [Related]
4. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Carter CJ; Pycock CJ Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685 [TBL] [Abstract][Full Text] [Related]
5. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate. Finn IB; Iuvone PM; Holtzman SG Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712 [TBL] [Abstract][Full Text] [Related]
6. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Miller FE; Heffner TG; Kotake C; Seiden LS Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194 [TBL] [Abstract][Full Text] [Related]
7. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Castall B; Marsden CD; Naylor RJ; Pycock CJ Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267 [TBL] [Abstract][Full Text] [Related]
9. Failure of amphetamine isomers to decrease hyperactivity in developing rats. Concannon JT; Schechter MD Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666 [TBL] [Abstract][Full Text] [Related]
10. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction. Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333 [TBL] [Abstract][Full Text] [Related]
11. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. Robbins TW; Roberts DC; Koob GF J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587 [TBL] [Abstract][Full Text] [Related]
12. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions. Minnema DJ; Rosecrans JA Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809 [TBL] [Abstract][Full Text] [Related]
13. Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Luthman J; Fredriksson A; Sundström E; Jonsson G; Archer T Behav Brain Res; 1989 Jul; 33(3):267-77. PubMed ID: 2547396 [TBL] [Abstract][Full Text] [Related]
14. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine. Clarke PB; Jakubovic A; Fibiger HC Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775 [TBL] [Abstract][Full Text] [Related]
15. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels. Luthman J; Herrera-Marschitz M; Lindqvist E Psychopharmacology (Berl); 1994 Dec; 116(4):443-50. PubMed ID: 7701047 [TBL] [Abstract][Full Text] [Related]
16. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny. Sachs C; Jonsson G Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547 [TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala. Deminière JM; Taghzouti K; Tassin JP; Le Moal M; Simon H Psychopharmacology (Berl); 1988; 94(2):232-6. PubMed ID: 3127850 [TBL] [Abstract][Full Text] [Related]
18. Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate. Fink JS; Smith GP Pharmacol Biochem Behav; 1979 Jul; 11(1):23-30. PubMed ID: 493296 [TBL] [Abstract][Full Text] [Related]
19. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Davids E; Zhang K; Tarazi FI; Baldessarini RJ Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378 [TBL] [Abstract][Full Text] [Related]
20. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi. Kelly PH; Roberts DC Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]